Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/1991
05/03/1991CA2045504A1 Magnetically controlled carrier with physiologically active agent and process for preparing thereof
05/03/1991CA2029216A1 Process of producing modified superoxide dismutase
05/02/1991EP0425282A2 Triazolo derivatives and process for their preparation
05/02/1991EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use
05/02/1991EP0424722A2 Substituted (quinolin-2-yl-methoxy)phenyl-thioureas
05/02/1991EP0424534A1 Pharmaceutical preparation for treatment of mastitis in animals and humans
05/01/1991WO1991006863A1 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
05/01/1991CA2069313A1 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
04/1991
04/30/1991US5011928 Analgesic and antiinflammatory derivatives of 1-acyl-4-arylalkylpiperazines
04/30/1991US5011844 Substituted 4-azatricyclo(22.3.1.04,9)octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them
04/30/1991US5011839 3(2H)pyridazinones for antagonistic agent against srs-a
04/28/1991WO1991006539A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991WO1991006538A1 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991WO1991006537A2 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991CA2070422A1 Substituted indole-, indene-, pyranoindole and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991CA2067138A1 Substituted benzoylbenzene-, biphenyl-and 2-oxazole-alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991CA2067135A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase
04/26/1991CA2028610A1 Triazolo derivatives and process for their preparation
04/26/1991CA2028314A1 Substituted (quinolin-2-yl-methoxy)phenyl-carbonylureas
04/24/1991EP0424193A2 Use of actinonin for the manufacture of a medicament for angiogenesis inhibition
04/24/1991EP0423326A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
04/23/1991US5010097 Collagenase inhibitors, antiarthritic agents
04/23/1991US5010059 Pharmaceutical products and lactosyl compounds
04/23/1991US5010058 Antinflammatory agents, autoimmune diseases, lupus
04/22/1991CA2028042A1 Substituted (quinolin-2-yl-methoxy)phenylthioureas
04/18/1991WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage
04/18/1991WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1)
04/18/1991WO1991005046A1 Granulocyte-colony stimulating factor receptors
04/18/1991WO1991005038A1 Blood-brain barrier model
04/18/1991WO1991004977A1 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
04/18/1991WO1991004664A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems
04/18/1991DE3933850A1 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins Cytolysis inhibitor (ZLI), these a blood plasma protein encoding DNA sequence, and a plasmid, a host organism and a method for obtaining this protein
04/18/1991CA2067803A1 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
04/18/1991CA2066046A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems
04/18/1991CA2027702A1 Pyridone products, preparation process, new intermediates obtained, application as drugs and pharmaceutical compositions containing them
04/17/1991EP0422889A2 Phenethanolamine compounds
04/17/1991EP0422878A1 (2-Imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
04/17/1991EP0422566A1 A process for the preparation of 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid derivatives
04/17/1991EP0422339A1 Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
04/17/1991EP0422329A1 Substituted dibenzofurans and methods of using same
04/17/1991EP0422328A2 Substituted isoquinolines and their use
04/17/1991EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m
04/17/1991EP0422079A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use
04/16/1991US5008374 IL-1α derivatives and drugs
04/16/1991US5008263 Diazepine antiallergy agents
04/16/1991US5008256 Gastrointestinal disorders
04/16/1991US5008247 Polysulfuric acid esters of bis-aldonamides and their derivatives, process for their preparation and medicaments
04/16/1991US5008242 Treatment of inflammation using 1-antichymotrypsin
04/16/1991US5008240 Polypeptide with amino acid sequence of cartilage inducing factor A or B
04/16/1991CA1283103C Substituted 2,3-dihydro-6-hydroxy-pyrimido ¬2,1-f|-purine- 4,8(1h,9h)-diones
04/16/1991CA1283098C Depolymerized hexosaminoglucan sulfates endowed with an antithrombotic, fibrinolytic, antiinflammatory activity, their process of preparation and related pharmaceutical compositions
04/13/1991WO1991005570A1 Radiation synovectomy compositions
04/11/1991CA2027262A1 Phenethanolamine derivatives
04/11/1991CA2027076A1 Process for preparation of 4-(4-isobutylphenyl)-butyr-aldehyde and its use for the preparation of (-)-4(2-chlorophenyl)-2[2-(4-isobutylphenyl)-ethyl]-6,9-dim ethyl-6h-thieno[3,2-f]1,2,4]-triazolo[4,3][1,4]diazepine
04/10/1991EP0421749A2 3-Aroyl-2-oxindole-1-carboxamides
04/10/1991EP0420849A1 Use of sucralfate
04/09/1991US5006555 Antiinflammatory, antithrombin, respiratory system disorder treatment
04/09/1991US5006549 Antiinflammatory agents
04/09/1991US5006539 Thromborane inhibitor
04/09/1991US5006337 For treating skin disorders
04/07/1991WO1991005043A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins
04/07/1991CA2042605A1 Cytolysis inhibitor proteins (cli), dna sequences coding for said proteins, and plasmids, host organisms, and processes for obtaining said proteins
04/03/1991EP0420762A2 Heterocyclic compounds having lipoxygenase inhibiting activity
04/03/1991EP0420571A2 6-and/or 7-substituted -1,2,3,4,4A,9B-hexahydro-8-hydroxydibenzofuran-3-ols as inhibitors of leukotriene biosynthesis
04/03/1991EP0420570A2 Trans 2,3-disubstituted-2,3-dihydro-5-hydroxy-benzofurans as inhibitors of leukotriene biosynthesis
04/03/1991EP0420511A2 Heterocyclic derivatives
04/03/1991EP0420232A2 Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions
04/03/1991EP0419878A1 Aprotinin variants and a recombinant method for the microbial preparation of these variants in homogeneously processed form
04/03/1991EP0419844A1 N-hydroxy-dibenz[b,e]oxepin-alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use in the manufacture of medicaments
04/03/1991EP0419561A1 Heterobicyclic compounds having antiinflammatory activity
04/03/1991EP0393190A4 Copolymers of vinyl alcohol with vinyl acetate, cross-linked by glutaric dialdehyde, method of obtaining them and a phramaceutical preparation based thereon
04/03/1991CN1050385A Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity
04/03/1991CN1050384A Substituted dibenzofurans and methods of using same
04/03/1991CN1050382A Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
04/03/1991CN1050381A Substituted isoquinolines and methods of using same
04/02/1991US5004742 Benzothiazine-1,1-dioxide derivatives
04/02/1991CA1282410C Process for the preparation of optically active ó-arylalkanoic acids and novel intermediates thereof
03/1991
03/30/1991WO1991005258A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region
03/30/1991CA2066674A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region
03/30/1991CA2026227A1 Heterocyclic compound
03/30/1991CA2024258A1 Heterocyclic derivatives
03/27/1991WO1991004733A1 Ibuprofen triturates and topical compositions containing same
03/27/1991EP0419411A2 Additional alkanophenones
03/27/1991EP0419210A1 Novel benzimidazole compounds and their use
03/27/1991EP0419132A2 Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
03/27/1991EP0419049A1 (Quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes
03/27/1991EP0418845A1 Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
03/27/1991CN1050198A Peptidase and isomerase inhibitors
03/27/1991CN1050190A Process for preparing sulphamoylthiophenes
03/27/1991CA2067131A1 Ibuprofen triturates and topical compositions containing same
03/26/1991WO1991004479A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress
03/26/1991US5003098 Administering a Myo-Inositol Triphosphate
03/26/1991US5002966 Adrenergic Stimulants
03/26/1991US5002941 Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
03/26/1991US5002938 Fungicide, Steroid, Alcohol and Diol and/or Triol Solvent, Hydroxyalkyl Cellulose
03/26/1991CA2067123A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress
03/26/1991CA2025479A1 6-and/or 7-substituted-1,2,3,4,4a 9b-hexahydro-8-hydroxydibenzofuran-3-ols as inhibitors of leukotriene biosynthesis
03/26/1991CA2025478A1 Trans 2,3-disubstituted-2,3-dihydro-5-hydroxybenzofurans as inhibitors of leukotriene biosynthesis
03/23/1991CA2025849A1 Benzimidazole compounds and their use
03/22/1991WO1991004058A2 Treatment of conditions and disease